How to buy Medibank shares | A$2.59
Own Medibank shares in just a few minutes.
Medibank Private Limited is an insurance—diversified business based in Australia. Medibank shares (MPL) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $2.59 – an increase of 4.44% over the previous week. Medibank has a trailing 12-month revenue of around $6.8 billion.
How to buy shares in Medibank
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Medibank. Find the share by name or ticker symbol: MPL. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medibank reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $2.59, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Medibank. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Medibank key stats
- Compare share trading platforms
- Is Medibank stock a buy or sell?
- Medibank performance over time
- Is Medibank suitable for ethical investing?
- Are Medibank shares over-valued?
- Medibank's financials
- How volatile are Medibank shares?
- Does Medibank pay a dividend?
- Other common questions
How has coronavirus impacted Medibank's share price?
Since the stock market crash in March caused by coronavirus, Medibank's share price has had significant negative movement.
Its last market close was $2.59, which is 11.00% down on its pre-crash value of $2.91 and 5.71% up on the lowest point reached during the March crash when the shares fell as low as $2.45.
If you had bought $1,000 worth of Medibank shares at the start of February 2020, those shares would have been worth $845.90 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $849.18.
Medibank share priceUse our graph to track the performance of MPL stocks over time.
Medibank shares at a glance
|Latest market close||AUDA$2.59|
|52-week range||AUDA$2.45 - AUDA$3.48|
|50-day moving average||AUDA$2.7274|
|200-day moving average||AUDA$2.8027|
|Dividend yield||AUDA$0.13 (5.08%)|
|Earnings per share (TTM)||AUDA$0.114|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Medibank stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Medibank price performance over time
|1 week (2020-09-14)||1.57%|
|1 month (2020-08-25)||-9.44%|
|3 months (2020-06-21)||N/A|
|6 months (2020-03-23)||0.39%|
|1 year (2019-09-21)||N/A|
|2 years (2018-09-21)||-10.38%|
|3 years (2017-09-21)||-11.60%|
|5 years (2015-09-21)||10.21%|
Is Medibank under- or over-valued?
Valuing Medibank stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medibank's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medibank's P/E ratio
Medibank's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Medibank shares trade at around 23x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Medibank's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $475.8 million (£0.0 million).
The EBITDA is a measure of a Medibank's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$6.8 billion|
|Operating margin TTM||6.69%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||7.67%|
|Return on equity TTM||16.84%|
|Market capitalisation||$6.8 billion|
TTM: trailing 12 months
Medibank's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medibank.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Medibank's total ESG risk score
Total ESG risk: 22.82
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medibank's overall score of 22.82 (as at 07/31/2020) is pretty good – landing it in it in the 29th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Medibank is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Medibank's environmental score
Environmental score: 3.11/100
Medibank's environmental score of 3.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Medibank's social score
Social score: 10.91/100
Medibank's social score of 10.91 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Medibank's governance score
Governance score: 6.29/100
Medibank's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Medibank is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Medibank's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Medibank scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Medibank has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||22.82|
|Total ESG percentile||29.04|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||2|
Medibank share dividends
Dividend payout ratio: 114.31% of net profits
Recently Medibank has paid out, on average, around 114.31% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.08% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medibank shareholders could enjoy a 5.08% return on their shares, in the form of dividend payments. In Medibank's case, that would currently equate to about A$0.13 per share.
Medibank's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 1 September 2020 (the "ex-dividend date").
Medibank share price volatility
Over the last 12 months, Medibank's shares have ranged in value from as little as $2.45 up to $3.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Medibank's is 0.2108. This would suggest that Medibank's shares are less volatile than average (for this exchange).
Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. The company operates through two segments, Health Insurance and Medibank Health. The Health Insurance segment offers private health insurance products, including hospital cover that provides members with health cover for hospital treatments; and ancillary cover, which offers members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also provides health insurance products to overseas visitors and overseas students. The Medibank Health segment offers health management and telehealth services to government and corporate customers, as well as distributes travel, life, and pet insurance products. Medibank Private Limited underwrites its health insurance products under the Medibank and ahm brands. The company was founded in 1976 and is based in Docklands, Australia.
Frequently asked questions
Ask an Expert